A phase II study of gemcitabine (G) and capecitabine (C) in patients with metastatic renal cell cancer (mRCC): A report of Cancer and Leukemia Group B #90008.
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Stadler, WM; Halabi, S; Ernstoff, MS; Barrier, R; Davila, E; Picus, J; Small, EJ
Published Date
- July 15, 2004
Published In
Volume / Issue
- 22 / 14
Start / End Page
- 385S - 385S
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 0732-183X
Conference Name
- 40th Annual Meeting of the American-Society-of-Clinical-Oncology
Conference Location
- New Orleans, LA
Conference Start Date
- June 5, 2004
Conference End Date
- June 8, 2004